GOOG
65
-4
DG
2
-6
BIIB
26
2
FLS
73
-2
NWL
44
-4
L
62
2
MUR
43
3
HRL
39
15
CVX
46
5
DVA
72
2
MS
74
-2
DHI
48
3
C
58
-2
COF
55
-3
FRT
39
-2
GOOGL
54
-2
F
43
-8
AMGN
44
5
GIS
26
3
AXP
66
2
GOOG
65
-4
DG
2
-6
BIIB
26
2
FLS
73
-2
NWL
44
-4
L
62
2
MUR
43
3
HRL
39
15
CVX
46
5
DVA
72
2
MS
74
-2
DHI
48
3
C
58
-2
COF
55
-3
FRT
39
-2
GOOGL
54
-2
F
43
-8
AMGN
44
5
GIS
26
3
AXP
66
2
Financhill
Back

Immunovant Vs. Perspective Therapeutics Industry Stock Comparison

Sell
50

IMVT
Immunovant

Last Price:
26.54
Seasonality Move:
2.57%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Sell
50
Immunovant (IMVT) is a Sell

Is Immunovant a Buy, Sell or Hold?

  • The current Immunovant [IMVT] share price is $26.17. The Score for IMVT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IMVT Stock Price Chart

What is Immunovant's stock price today?

  • The Immunovant share price today is $26.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

IMVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 36.37 Sell
Chaikin Money Flow: 933944 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.57 - 30.79) Sell
Bollinger Bands (100): (27.85 - 31.01) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

IMVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.62 Sell
20-day SMA: 29.1 Sell
50-day SMA: 29.18 Sell
200-day SMA: 30.02 Sell
8-day EMA: 27.18 Sell
20-day EMA: 28.44 Sell
50-day EMA: 29.12 Sell
200-day EMA: 29.59 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Immunovant Earnings Growth & IMVT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $1.15 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Immunovant Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):